Sanne de Bruin

39 Transfusion practice in the non-bleeding critically ill; an international online survey – The TRACE Survey References 1. Vincent J-L, Jaschinski U, Wittebole X, Lefrant J-Y, Jakob SM, Almekhlafi GA, et al. Worldwide audit of blood transfusion practice in critically ill patients. Crit Care [Internet]. 2018 Dec 19;22(1):102. Available from: https://ccforum.biomedcentral.com/articles/10.1186/s13054-018-2018-9 2. Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med [Internet]. 2002 Aug;30(8):1765–71. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/2163790 3. Walsh TS, Stanworth SJ, Prescott RJ, Lee RJ, Watson DM, Wyncoll D, et al. Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units. Crit Care Med [Internet]. 2010 Oct;38(10):1939–46. Available from: http://www. ncbi.nlm.nih.gov/pubmed/20639745 4. Whitaker BI, Rajbhandary S, Harris A. 2013 AABB Blood Survey Report. 2013; 5. Bolton-Maggs PHB. SHOT conference report 2016: serious hazards of transfusion - human factors continue to causemost transfusion-related incidents. Transfus Med [Internet]. 2016 Dec;26(6):401–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27995700 6. Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J, Blajchman MA, et al. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev [Internet]. 2005 Jan;19(1):2–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15830325 7. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): An update. Blood Rev. 2007;21(6):327–48. 8. Hébert PC,Wells G, BlajchmanMA, Marshall J, Martin C, Pagliarello G, et al. AMulticenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care. N Engl J Med [Internet]. 1999 Feb 11;340(6):409–17. Available from: http://www.nejm.org/doi/abs/10.1056/NEJM199902113400601 9. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, et al. Anemia and blood transfusion in critically ill patients. J AmMed Assoc [Internet]. 2002;288(12):1499–507. Available from: http://www. ncbi.nlm.nih.gov/pubmed/12243637 10. Villanueva C, Colomo A, Bosch A, Concepción M, Hernandez-Gea V, Aracil C, et al. Transfusion Strategies for Acute Upper Gastrointestinal Bleeding. N Engl J Med [Internet]. 2013;368(1):11–21. Available from: http://www.nejm.org/doi/10.1056/NEJMoa1211801 11. Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med [Internet]. 2014 Oct 9;371(15):1381– 91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25270275 12. Müller MC, Arbous MS, Spoelstra-de Man AM, Vink R, Karakus A, Straat M, et al. Transfusion of fresh- frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME). Transfusion [Internet]. 2015 Jan;55(1):26–35; quiz 25. Available from: http://www. ncbi.nlm.nih.gov/pubmed/24912653 13. Schofield WN, Rubin GL, Dean MG. Appropriateness of platelet, fresh frozen plasma and cryoprecipitate transfusion in New South Wales public hospitals. Med J Aust. 2003;178(3):117–21. 14. Qureshi H, Lowe D, Dobson P, Grant-Casey J, Parris E, Dalton D, et al. National comparative audit of the use of platelet transfusions in the UK. Transfus Clin Biol. 2007;14(6):509–13. 2